Vapotherm was going to have trouble meeting surging COVID-19 demands, then Viant stepped in
In this week’s episode, we interview Joe Army, CEO of Vapotherm, and Alton Shader, CEO of Viant. First. We’ll follow Army’s heartful move into Medtech, which includes his current role as CEO of Vapotherm, maker of the high flow nasal cannula that proved to be a highly effective tool to treat patients hospitalized with COVID-19. We’ll later learn that Vapotherm’s ability to supply hospitals with this life-saving technology was in doubt due to labor shortages. But Shader details how the contract manufacturer stepped in to immediately help with Vapotherm’s dilemma. The interview is a taste of the discussion Vapotherm and Viant will lead at DeviceTalks Boston on May 10. Go to devicetalks.com to register.
We also bring in former Johnson & Johnson executive Peter Stebbins to tell us about his upcoming interview with Frank Doyle III, dean of Harvard’s John A. Paulson School of Engineering and Applied Sciences. Doyle will be our keynote interview subject on the morning of May 10 at DeviceTalks Boston.
Stebbins also provides his experience and insights to this week’s Newmarker’s Newsmakers including news from Medtronic, Masimo, Boston Scientific, GE Healthcare and FitBit.
Medtronic’s CEO would like to put the tech in medtech
Masimo completes acquisition of Sound United
Boston Scientific wins FDA approval for imaged-guided software for DBS therapy
GE Healthcare, Elekta collaborate to expand precision radiation therapy access
FDA clears Fitbit PPG algorithm to detect AFib